Abstracts Archive - Page 949 of 2607 - ACR Meeting Abstracts

Abstract Number: 1689 • ACR Convergence 2020
Unexpectedly High Incidence of Kawasaki Disease in a Well-Characterized Population in Atlantic Canada
Abdulrahman Alkanhal¹, Joseph Saunders², Fajer Altammar³, Adam Huber⁴, Andrew Lynk², Alison MacLeod⁵, Oliva Ortiz-Alvarez⁶, Meighan Adams², Suzanne Ramsey⁷, Elizabeth Stringer⁸, Andrew Warren² and Bianca Lang⁹, ¹University of Alberta, Edmonton, AB, Canada, ²Dalhousie University, Halifax, Canada, ³Mcmaster University, Hamilton, Canada, ⁴Dalhousie University, Halifax, NS, Canada, ⁵Annapolis Valley Health, Kentville, Canada, ⁶St Martha's Regional Hospital, Antigonish, Canada, ⁷IWK Health Centre, Dalhousie University, Halifax, NS, Canada, ⁸IWK Health Centre, Halifax, NS, Canada, ⁹Dalhousie University - Halifax, Halifax, NS, Canada
Background/Purpose: Kawasaki Disease (KD), a systemic vasculitis of unknown etiology, is now the leading cause of acquired heart disease in children in North America. Its…
Abstract Number: 1690 • ACR Convergence 2020
Henoch-Schönlein Purpura Nephritis: Different Histological Classifications, but Which One Is Most Strongly Associated to the Outcome of the Disease? Pilot Study of the Paediatric Rheumatology European Society Vasculitis Working Party
Martina Held¹, Mario Sestan¹, Marijana Coric¹, Stela Bulimbasic¹, Teresa Giani², Neil Martin³, Nastasia Cekada¹, Sasa Srsen⁴, Ana Gudelj Gracanin⁵, Domagoj Kifer⁶, Merav Heshin⁷, Angelo Ravelli⁸, Rolando Cimaz⁹, Seza Ozen¹⁰, Alenka Gagro¹¹, Marijan Frkovic¹ and Marija Jelusic¹, ¹University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia, Zagreb, Grad Zagreb, Croatia, ²Anna Meyer Children’s Hospital, Florence, Italy, Florence, Toscana, Italy, ³Royal Hospital for Children, Glasgow, United Kingdom, Glasgow, Scotland, United Kingdom, ⁴University Hospital Centre Split, University of Split School of Medicine, Split, Croatia, Split, Splitsko-Dalmatinska, Croatia, ⁵University Hospital Dubrava, University of Zagreb School of Medicine, Zagreb, Croatia, Zagreb, Grad Zagreb, Croatia, ⁶Faculty of Pharmacy and Biochemistry, Zagreb, Croatia, Zagreb, Grad Zagreb, Croatia, ⁷Dana Dwek Children's Hospital, Tel Aviv, Israel, Tel Aviv, Tel Aviv, Israel, ⁸Università degli Studi di Genova, Genoa, Italy, ⁹ASST Gaetano Pini-CTO Institute and Università degli Studi di Milano, Milan, Italy, Milan, Italy, ¹⁰Department of Pediatric Rheumatology, Hacettepe University, Ankara, Turkey, Ankara, Turkey, ¹¹Children's Hospital Zagreb, Josip Juraj Strossmayer University of Osijek, Medical Faculty Osijek, Zagreb, Croatia, Zagreb, Grad Zagreb, Croatia
Background/Purpose: Henoch-Schönlein purpura nephritis (HSPN) is the main and almost the only cause of morbidity and mortality among children suffering from this most common vasculitis…
Abstract Number: 1691 • ACR Convergence 2020
Applied Geostatistics in Pediatric Rheumatology – Spatial Clustering of IgA Vasculitis
Matej Sapina¹, Marijan Frkovic², Mario Sestan², Sasa Srsen³, Aleksandar Ovuka⁴, Mateja Batnozic Varga⁵, Nastasia Cekada², Karolina Kramaric⁶, Dario Brdaric⁷, Kresimir Milas⁵, Alenka Gagro⁸ and Marija Jelusic², ¹University Hospital Centre Osijek, Josip Juraj Strossmayer University of Osijek, Medical Faculty Osijek, Faculty of Dental Medicine and Health, Osijek, Croatia, Osijek, Osjecko-Baranjska, Croatia, ²University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia, Zagreb, Grad Zagreb, Croatia, ³University Hospital Centre Split, University of Split School of Medicine, Split, Croatia, Split, Splitsko-Dalmatinska, Croatia, ⁴University Hospital Centre Rijeka, University of Rijeka School of Medicine, Rijeka, Croatia, Rijeka, Primorsko-Goranska, Croatia, ⁵University Hospital Centre Osijek, Josip Juraj Strossmayer University of Osijek, Medical Faculty Osijek, Croatia, Osijek, Osjecko-Baranjska, Croatia, ⁶University Hospital Centre Osijek, Josip Juraj Strossmayer University of Osijek, Faculty of Dental Medicine and Health Osijek, Croatia, Osijek, Osjecko-Baranjska, Croatia, ⁷Josip Juraj Strossmayer University of Osijek, Faculty of Dental Medicine and Health, Institute of Public Health for the Osijek-Baranja County, Osijek, Croatia, Osijek, Osjecko-Baranjska, Croatia, ⁸Children's Hospital Zagreb, Josip Juraj Strossmayer University of Osijek, Medical Faculty Osijek, Zagreb, Croatia, Zagreb, Grad Zagreb, Croatia
Background/Purpose: IgA vasculitis (IgAV) is the most common childhood vasculitis, which etiology seems to be related to the combination of genetic as well as environmental…
Abstract Number: 1692 • ACR Convergence 2020
Poor Physical Activity Levels and Cardiorespiratory Fitness Among Patients with Childhood-Onset Takayasu Arteritis in Remission
Camilla Astley¹, Saulo Gil², Gleice Clemente³, Maria Teresa Terreri⁴, Lucia Campos⁵, Nadia Aikawa⁵, Ana Lucia de-Sá Pinto², Rosa Pereira⁵, Hamilton Roschel² and Bruno Gualano², ¹University of Sao Paulo, Sao Paulo, Sao Paulo, Brazil, ²University of Sao Paulo, Sao paulo, Brazil, ³Federal University of Sao Paulo, Sao Paulo, Brazil, ⁴Federal University of São Paulo, São Paulo, Brazil, ⁵Hospital das Clínicas, Faculdade de Medicina da Universidade de Sao Paulo (HCFMUSP), Sao Paulo, Sao Paulo, Brazil
Background/Purpose: Childhood-onset Takayasu Arteritis (c-TA) is a rare, granulomatous, chronic large-vessel vasculitis that involves mostly the aorta and its major branches with a high mortality…
Abstract Number: 1693 • ACR Convergence 2020
Evaluation of B-cell Depletion with Rituximab and IVIG Concurrent Treatment in Pediatric Autoimmune Brain Disease
Alexis Wilsey¹, Laura Cannon², Stephanie Johannes² and Heather Van Mater², ¹Duke University School of Medicine, Durham, ²Duke University, Durham, NC
Background/Purpose: Rituximab is standard therapy for autoimmune brain disease (ABD) including autoimmune encephalitis (AE) and Neuromyelitis Optica Spectrum Disease (NMOSD). Recommendations for continuing concurrent intravenous…
Abstract Number: 1694 • ACR Convergence 2020
Risk Factors Associated with Pneumocystis Jirovecii Pneumonia in Juvenile Myositis in North America
Sara Sabbagh¹, Jessica Neely², Albert Chow³, Marietta DeGuzman⁴, Jamie Lai⁵, Svetlana Lvovich⁶, Tara McGrath⁷, Maria Pereira⁸, Iago Pinal-Fernandez⁹, Jordan Roberts¹⁰, Kelly Rouster-Stevens¹¹, Heinrike Schmeling¹², Anjali Sura¹³, Gabriel Tarshish¹⁴, Lori Tucker¹⁵, Lisa G. Rider¹⁶ and Susan Kim¹⁷, ¹Medical College of Wisconsin, Fox Point, WI, ²UCSF, San Francisco, CA, ³Loma Linda University, San Bernardino, CA, ⁴Baylor College of Medicine, Houston, ⁵University of Colorado, The Woodlands, TX, ⁶St Christopher's Hospital for Children, Philadelphia, PA, ⁷University of British Columbia, Vancouver, BC, Canada, ⁸Baylor College of Medicine, Houston, TX, ⁹National Institutes of Health, Bethesda, MD, ¹⁰Boston Children's Hospital, Boston, MA, ¹¹Emory University/Children's Healthcare of Atlanta, Atlanta, GA, ¹²University of Calgary, Calgary, AB, Canada, ¹³Upstate University Hospital, Syracuse, NY, ¹⁴Children's Hospital at Montefiore, New York, NY, ¹⁵BC Children's Hospital, Vancouver, BC, Canada, ¹⁶Environmental Autoimmunity Group, Clinical Research Branch, NIEHS, NIH, Garrett Park, MD, ¹⁷UCSF Benioff Children's Hospital, San Francisco, CA
Background/Purpose: Pneumocystis jirovecii pneumonia (PJP) is associated with significant morbidity and mortality in adult myositis patients; however, few studies have examined PJP in juvenile myositis…
Abstract Number: 1695 • ACR Convergence 2020
Anti-Melanoma Differentiation Associated Protein 5 (MDA5) Positive Juvenile Dermatomyositis: Focus on the Lung
David Moreno McNeill¹, Miriah Gillispie-Taylor², Kevin Baszis³, Edouard Sayad¹, Manuel Silva Carmona¹ and Tiphanie Vogel¹, ¹Baylor College of Medicine/Texas Children's Hospital, Houston, TX, ²Baylor College of Medicine, Houston, ³Washington Univ School of Medicine, St Louis, MO
Background/Purpose: A subset of juvenile dermatomyositis (JDM), clinically amyopathic dermatomyositis (CADM), is uncommon and mainly described in adults. CADM is classically characterized by skin ulcerations,…
Abstract Number: 1696 • ACR Convergence 2020
Measuring Quality Improvement from CME Participants: Results from the RAPID® CME Initiative
Stephen Bender¹, Michael Weinblatt² and Daniel Duch¹, ¹FACTORx, Cherry Hill, NJ, ²Brigham and Women's Hospital, Boston, MA
Background/Purpose: Medical claims data have been used since 2008 to measure the implementation of the diagnostic and referral strategies resulting from participation in RAPID® CME…
Abstract Number: 1697 • ACR Convergence 2020
Immune Related Adverse Events from Checkpoint Inhibitor Therapy: Survey of Hospitalists’ Awareness and Experiences
Cassandra Calabrese¹, Alexa Meara² and Varalakshmi Janamanchi¹, ¹Cleveland Clinic, Cleveland, OH, ²Ohio State University Wexner School of Medicine, Columbus, OH
Background/Purpose: The introduction of immunologic checkpoint inhibitor therapy (ICI) has caused a paradigm shift in the world of cancer treatment. Their use, however, is attended…
Abstract Number: 1698 • ACR Convergence 2020
Polyarthritis Workup in Primary Care Setting : How Are We Doing?
Ruhani Desai¹, Cassandra Calabrese², Neel Patel³ and Jessica Donato⁴, ¹Cleveland Clinic Foundation, DeLand, FL, ²Cleveland Clinic, Cleveland, OH, ³Case Western Reserve University, Cleveland, OH, ⁴Cleveland Clinic Foundation, Cleveland
Background/Purpose: Joint pain is a common presenting complaint in Primary Care with around 54.4 million adults diagnosed with some form of arthritis per 2013 CDC survey. Polyarthritis…
Abstract Number: 1699 • ACR Convergence 2020
Training Residents to ‘Choose Wisely’ When Testing for Antinuclear Antibodies
Iman Qaiser¹, Tracy Koehler¹ and Richard Martin², ¹Mercy Health Saint Mary's, Grand Rapids, MI, ²Michigan State University College of Human Medicine, Grand Rapids, MI
Background/Purpose: In many hospitals residents are the first providers to evaluate new patients. Consequently, residents often initiate the work-up of newly admitted patients. Multiple studies…
Abstract Number: 1700 • ACR Convergence 2020
Curricular Implementation of the Rheumatic Disease Patient Expert Program: The Students’ Perspective
Eleni Sophocleous¹, Andri Phoka² and Konstantinos Parperis³, ¹University of Cyprus Medical school, Nicosia, Cyprus, ²Cyprus League Against Rheumatism, Nicosia, Cyprus, ³University of Cyprus Medical School, Nicosia, Nicosia, Cyprus
Background/Purpose: Medical education can be enriched by embracing patient involvement so that students can learn about rheumatic diseases (RMD) from patient experts. Patient experts have…
Abstract Number: 1701 • ACR Convergence 2020
Development and Validity Evidence for a Tool to Assess the Performance of Shoulder Injections
Andrea Ramirez-Gomez¹, Amber Deptola¹, Colin Diffie², John Metzler¹, Peter McDonnell¹, Nathan Olafsen¹ and Lisa Zickuhr³, ¹Washington University School of Medicine, St. Louis, MO, ²Washington University, Saint Louis, MO, ³Washington University/B-JH/SLCH Consortium, St. Louis, MO
Background/Purpose: Shoulder pain is common. Subacromial bursa and intra-articular glucocorticoid injections can provide pain relief while avoiding the risks associated with systemic therapies. The American…
Abstract Number: 1702 • ACR Convergence 2020
RA-Related Knowledge and Skills of Rheumatology Fellows Among 20 US Academic Institutions
Sandeep Agarwal¹, Rebecca Manno², Kristina Fajardo³, Laura Simone³, Jeff Carter³ and Tamar Sapir³, ¹Baylor College of Medicine, Houston, TX, ²Johns Hopkins University School of Medicine, St. Thomas, Virgin Islands, U.S., U.S. Virgin Islands, ³PRIME Education, LLC, Fort Lauderdale, FL
Background/Purpose: As the rheumatology workforce experiences an alarming shortage, it is critical that rheumatology fellows receive advanced training experiences to reinforce their commitment to rheumatology…
Abstract Number: 1703 • ACR Convergence 2020
Gender Equity in Academic Rheumatology – Is There a Gender Gap at European Rheumatology Congresses?
Neelam Hassan¹, Leonieke van Mens², Uta Kiltz³, Concha Delgado⁴, Pavel Ovseiko⁵, Laure Gossec⁶ and Laura Coates⁷, ¹Musculoskeletal Research Unit, University of Bristol, UK., Bristol, United Kingdom, ²Clinical Immunology & Rheumatology, Amsterdam Rheumatology and immunology Center, Academic Medical Center/University of Amsterdam, amsterdam, Netherlands, ³Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Herne, Germany, ⁴Hospital Clínico Universitario Lozano Blesa. Zaragoza., Zaragoza, Spain, ⁵Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom, ⁶Sorbonne Université and Hôpital Universitaire Pitié Salpêtrière, Paris, France, ⁷University of Oxford, Oxford, United Kingdom
Background/Purpose: While increasing numbers of women are choosing rheumatology, they remain underrepresented in academic medicine, particularly in senior leadership roles. The reasons for this are…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].